The Supreme Cannabis Company, Inc. (“Supreme Cannabis” or the “Company”) (FIRE.TO) (SPRWF) (53S1.F) today announced the completion of its first international cannabis shipment from Canada into Israel . Supreme Cannabis partnered with Breath of Life International Ltd. (“BOL Pharma”), Israel’s largest and leading producer of medical cannabis and cannabis products, to offer Truverra-branded premium medical cannabis to patients in Israel .

“This transaction represents a new international revenue opportunity for Supreme Cannabis and builds Truverra’s global medical brand in one of the most sophisticated medical cannabis markets in the world,” said Colin Moore , Interim President and CEO of Supreme Cannabis. “With the support of BOL Pharma, we navigated both Canada and Israel’s complex regulatory landscapes to achieve compliance with regulatory authorities in both countries, including Health Canada, the Canadian Food Inspection Agency and Israel’s Ministry of Health and Ministry of Agriculture and Rural Development. We benefitted from BOL Pharma’s skilled team, international experience and solidified position as a leading medical cannabis company in Israel . As we pursue capital-light international opportunities, we will continue to look to Jeff Adams , Truverra’s CEO, and his exceptional team to build Truverra’s medical brand globally.”

“We are pleased to address the growing demand for premium indoor grown medical cannabis product in Israel through our first cannabis import from Canada . Supreme Cannabis is a partner that shares our high standards for quality and respect for patients and consumers,” said Dr. Tamir Gedo , CEO of BOL Pharma. “On March 30 , Truverra products became available across pharmacies in Israel and we are already receiving positive feedback from patients. We look forward to continuing to work with Supreme Cannabis and to offering Truverra’s premium medical cannabis to patients in Israel .”

BOL Pharma has been involved in researching and developing cannabis-based products for 13 years. It is the largest medical cannabis company in Israel and the only one to handle all stages of cultivation and production, ensuring compliance with the strictest standards set by the Israeli Ministry of Health and EU-GMP conditions. BOL Pharma is distributing Truverra’s medical cannabis in 10-gram containers to its network of pharmacies across Israel .

Truverra’s cannabis was grown at Supreme Cannabis’ 440,000 square foot premium indoor hybrid cultivation facility (the “7ACRES Facility”) in Kincardine, Ontario . The Truverra branded medical cannabis was purposefully grown and allocated to this international medical opportunity. Supreme Cannabis continues to operate internationally in the EU and UK through Truverra’s CBD e-commerce business (truverra.com).

COVID-19 Corporate Update

“As an essential business in Ontario and other Canadian provinces, Supreme Cannabis has the privilege to continue to produce products for our consumers, to provide income opportunities to our employees and to continue to support the communities we operate in,” said Colin Moore .

Supreme Cannabis continues to work to mitigate risk and manage disruption to its operations with the implementation of remote work when possible and increased precautionary measures at its facilities, including, limited shift sizes, separation between shifts, additional sterilization processes, staggered breaks, and continued access to personal protective equipment such as gloves and masks. These health, safety and sanitation measures have been applied in addition to the Company’s usual best-practices.